EMPALIX-S 25/100

EMPALIX-S 25/100 contains Empagliflozin 25 mg + Sitagliptin 100 mg, a strong dual therapy for effective management of type 2 diabetes. Empagliflozin works by removing excess glucose through urine, while Sitagliptin enhances insulin release and controls glucose production. This combination provides better and sustained glycemic control, along with added benefits like weight reduction and cardiovascular protection, making it suitable for patients needing intensified therapy.

Send Enquiry

Parturient ut id tellus vulputatre ac ultrlices a part ouriesnt sapien dignissim partu rient a a inter drum vehicula. Ornare metus laoreet tincidunt eros rolem tristique pretium malada.

Cras rhoncus vivamus luctus platea arcu laoreet selm. Curae est condenectus sed hac a parturient vestibulum.

MORE PRODUCTS